Hypoglycemic effect of orally administered resistant dextrins prepared with different acids on type 2 diabetes mice induced by high-fat diet and streptozotocin

Int J Biol Macromol. 2024 Oct;277(Pt 4):134085. doi: 10.1016/j.ijbiomac.2024.134085. Epub 2024 Aug 9.

Abstract

A comparative study was performed to investigate the physicochemical properties and protective effects of hydrochloric acid-resistant dextrin (H-RD), citric acid-resistant dextrin (C-RD) and tartaric acid-resistant dextrin (T-RD) on the metabolic disorders and intestinal microbiota for type 2 diabetes mellitus (T2DM) mice. T-RD had the minimum molecular weight, with the highest short chain (DP 6-12) proportion and resistant starch content. After 4-week intervention with the three resistant dextrins, the body weight and fasting blood glucose of T2DM mice were improved significantly, accompanied by the reduction of serum indexes (TG, TC, LDL-C, ALT, AST, CRE, BUN, FINS, and GSP), but the serum HDL-C and liver glycogen levels increased. Among the three RDs intervention groups, T-RD showed the most significant improvement, followed by C-RD and finally H-RD. The 16 s rDNA results indicated that oral administration of resistant dextrins favored the proliferation of specific gut microbiota, including Faecalibaculum, Parabacteroides and Dubosiella, and reduced the ratio of Firmicutes/Bacteroidota, which is beneficial for reducing insulin resistance. Herein, the findings supported that the resistant dextrins exhibited a remission effect on T2DM, providing a basis for the development of functional food adjuvants for T2DM treatment.

Keywords: Gut microbiota; Hypoglycemic; Resistant dextrin; Type 2 diabetes.

MeSH terms

  • Acids / chemistry
  • Administration, Oral
  • Animals
  • Blood Glucose* / drug effects
  • Body Weight / drug effects
  • Dextrins* / chemistry
  • Dextrins* / pharmacology
  • Diabetes Mellitus, Experimental* / drug therapy
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / metabolism
  • Diet, High-Fat* / adverse effects
  • Gastrointestinal Microbiome* / drug effects
  • Hypoglycemic Agents* / pharmacology
  • Insulin Resistance
  • Male
  • Mice
  • Streptozocin

Substances

  • Dextrins
  • Hypoglycemic Agents
  • Blood Glucose
  • Streptozocin
  • Acids